← Open Payments lookup

WEI WANG: Open Payments

NPI 1902813876 · TENAFLY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,193 in 28 payments from 9 companies in 2025. Trend: 2023 $17,569 · 2024 $10,784 · 2025 $6,193

Speaker / faculty: $5,500Food & beverage: $621Education: $71
CompanyPaymentsAmount
ABBVIE INC.6$5,765
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$143
Teva Pharmaceuticals USA, Inc.2$89
Otsuka America Pharmaceutical, Inc.4$70
Alkermes, Inc.2$37
E.R. Squibb & Sons, L.L.C.2$30
SANOFI PASTEUR INC.1$23
Boston Scientific Corporation1$18
Vanda Pharmaceuticals Inc.1$17

Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, ABILIFY MAINTENA, EXALT Model D.

Industry payments across NJ — which companies pay providers there.